Christian Lindhé

Partner
  • Malmö
  • Languages:
    Swedish, English

Mentions

Christian Lindhé is ranked as Notable practitioner at IFLR 1000 2019

Business Sectors

Education

  • University of Lund (LL M, 2006)
  • Lund University (Bachelor of Science in Business and Economics, 2006)

Other qualifications

  • B Sc

Awards

Mandates

Mandate November 29, 2024

Vinge advises Active Biotech in connection with rights issue

Vinge advises Active Biotech AB (publ) in connection with a rights issue of approximately SEK 43 mil…

Mandate November 13, 2024

Vinge advises Cantargia in connection with rights issue

Vinge advises Cantargia AB (publ) in connection with a rights issue of approximately SEK 170 million…

Mandate September 26, 2024

Vinge advises ITAB on its acquisition of HMY

ITAB Shop Concept AB (publ) has entered into an agreement intended to lead to the acquisition of Fin…

Mandate April 19, 2024

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SE…

Mandate February 05, 2024

Vinge advises 1Vision Biogas on its public offer for Biokraft

1Vision Biogas AB, a company controlled by Aneo, HitecVision and St1, has made a public mandatory bi…

Mandate December 21, 2023

Vinge advises Active Biotech on rights offering

Active Biotech AB (publ) (Nasdaq Stockholm) has carried out a rights issue of approximately SEK 51 m…

Mandate December 21, 2023

Vinge advises Trianon in connection with tender offer for subordinated sustainable capital securities

Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with its partial tender offer for…

Mandate November 01, 2023

Vinge advises Cantargia in connection with directed share issue

Vinge advises Cantargia AB (publ) in connection with a directed share issue of approximately SEK 59…

Mandate September 28, 2023

Vinge advises SAGA Diagnostics AB on convertible note issue

SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a converti…

Mandate May 19, 2023

Vinge advises IBT in connection with rights offering

Vinge advises Infant Bacterial Therapeutics AB (publ) in connection with its rights offering of appr…

Mandate December 19, 2022

Vinge advises SiB Solutions

Vinge advises SiB Solutions in connection with an investment from Scania Growth Capital (SGC).

Mandate December 09, 2022

Vinge advises BHG in connection with directed share issue

Vinge advises BHG Group AB (publ) in connection with a directed share issue of SEK 800 million throu…

Mandate November 24, 2022

Vinge advises Aneo on its public offer for Scandinavian Biogas

Aneo Renewables Holding AS has made a public mandatory bid for all shares in Scandinavian Biogas Fue…

Mandate November 24, 2022

Vinge advised Aneo in connection with the directed share issue by Scandinavian Biogas

Scandinavian Biogas Fuels International AB has carried out a directed share issue of SEK 326 million…

Mandate September 01, 2022

Vinge advises Xintela

Vinge has advised Xintela in connection with the mandatory public offer from Flerie Invest AB.

Mandate August 05, 2022

Vinge advises Active Biotech on rights offering

Active Biotech AB (publ) (Nasdaq Stockholm) carries out a rights issue of approximately SEK 55 milli…

Mandate June 30, 2022

Vinge advises Cantargia in connection with rights issue

Vinge advises Cantargia AB (publ) in connection with a fully covered rights issue of approximately S…

Mandate May 05, 2022

Vinge advises BHG Group on directed share issue

Vinge advises BHG Group AB (publ) in connection with a directed share issue of SEK 1.0 billion throu…

Mandate January 13, 2022

Vinge advises Oncorena

Vinge advises Oncorena Holding AB in connection with an investment of initially SEK 66 million from…

Mandate November 23, 2021

Vinge advises Trianon on directed share issue

Vinge advises Fastighets AB Trianon (publ) in connection with a directed share issue of approximatel…

Mandate October 13, 2021

Vinge advises Haypp Group in connection with the listing on Nasdaq First North Growth Market

Vinge advises Haypp Group AB (publ) (“Haypp Group”) in connection with the listing on Nasdaq First N…

Mandate September 22, 2021

Vinge advised Bactiguard in connection with a directed share issue

Vinge has advised Bactiguard Holding AB (publ) in connection with a directed share issue to AMF wher…

Mandate August 27, 2021

Vinge advises Trianon on its mandatory bid for Signatur Fastigheter

Fastighets AB Trianon has made a public mandatory bid for all shares in Signatur Fastigheter AB (pub…

Mandate July 26, 2021

Vinge has advised Lifco AB in connection with its establishment of an MTN program

Vinge has advised Lifco AB in connection with its establishment of an MTN program with a framework a…

Mandate July 02, 2021

Vinge advises Profoto in connection with the listing on Nasdaq Stockholm

Vinge advises Profoto Holding AB (publ) in connection with the listing on Nasdaq Stockholm. The pros…

Mandate June 11, 2021

Vinge advises BHG Group in connection with the acquisition of HYMA Skog & Trädgård

Vinge is advising BHG Group AB (publ) in connection with its acquisition of 92.2% of the shares in H…

Mandate February 04, 2021

Vinge advises BHG Group on directed share issue

Vinge advises BHG Group AB (publ) in connection with a directed share issue of approximately SEK 1.6…

Mandate December 18, 2020

Vinge advises Fastighets AB Trianon in connection with its listing on Nasdaq Stockholm

Vinge has advised Fastighets AB Trianon (publ) in connection with its list change from Nasdaq First…

Mandate December 17, 2020

Vinge advised Cantargia on a directed share issue

Vinge advised Cantargia AB (publ) in connection with a directed share issue of SEK 564 million to a…

Mandate December 10, 2020

Vinge advised Active Biotech on its rights offering

Vinge advised Active Biotech AB (publ) in connection with its rights offering.

Mandate November 27, 2020

Vinge advises Re:NewCell on its IPO

Vinge advises Re:NewCell AB in connection with its listing on Nasdaq First North Premier Growth Mark…

Mandate November 05, 2020

Vinge advises BioGaia on directed share issue

Vinge advises BioGaia AB (publ) in connection with a directed share issue of approximately SEK 1.1 b…

Mandate September 03, 2020

Vinge advises BIMobject on directed share issue

BIMobject AB (publ) makes a directed share issue of approximately SEK 304 million to selected Swedis…

Mandate July 27, 2020

Vinge advises BHG Group on its takeover bid for Sleepo

BHG Group AB (publ) has made a recommended cash offer to the shareholders of Sleepo AB (publ).

Mandate July 10, 2020

Vinge advised Trianon on directed share issue

Vinge advised Fastighets AB Trianon in connection with a directed share issue of SEK 115 million thr…

Mandate July 07, 2020

Vinge advised IVISYS on directed share issue

Vinge advised IVISYS AB in connection with a directed share issue through an accelerated book buildi…

Mandate July 01, 2020

Vinge has advised Magle Chemoswed Holding AB in connection with its listing on Nasdaq First North Growth Market

Vinge has provided capital markets and transaction advice in connection with Magle Chemoswed Holding…

Mandate February 20, 2020

Vinge advises Cantargia on its directed share issue

Cantargia AB (publ) makes a directed share issue of approximately SEK 410 million to a number of Swe…

Mandate December 02, 2019

Vinge advised Lifco on MTN program

Vinge has advised Lifco AB in connection with its establishment of an MTN program with a framework a…

Mandate December 02, 2019

Vinge advised Trianon on directed share issue

Vinge advised Fastighets AB Trianon in connection with a directed share issue of SEK 210 million thr…

Mandate September 12, 2019

Vinge advised ZetaDisplay on bond issue

ZetaDisplay AB (publ) has issued a 3.5 year senior unsecured bond loan of SEK 300 million, within a…

Mandate August 26, 2019

Vinge advised Enea on directed share issue

Vinge advised Enea AB (publ) in connection with a directed share issue of SEK 271 million through an…

Mandate March 25, 2019

Vinge advises Cantargia on directed share issue

Cantargia AB (publ) makes a directed share issue of approximately SEK 106 million to a number of Nor…

Mandate March 14, 2019

Vinge advises Active Biotech on real estate transaction

Active Biotech AB (publ) has entered an agreement regarding sale of the property Forskaren 1 in Lund…

Mandate January 08, 2019

Vinge advises Fagerhult

AB Fagerhult (publ) has entered into an agreement to acquire iGuzzini illuminazione S.p.A. for EUR 3…

Mandate September 25, 2018

Vinge advised Cantargia on its Nasdaq Stockholm main market listing

The shares of Cantargia AB (publ) have been admitted to trading on the main market of Nasdaq Stockho…

Mandate September 10, 2018

Vinge advised IBT on its Nasdaq Stockholm main market listing

The shares of Infant Bacterial Therapeutics AB (publ) have been admitted to trading on the main mark…

Mandate July 11, 2018

Vinge advised BIMobject on directed share issue

BIMobject AB (publ) has completed a directed share issue of SEK 240 million to EQT Ventures.

Mandate May 02, 2018

Vinge advised Lifco on bond issue

Lifco AB (publ) has issued two unsecured bond loans of in total SEK 1,750 million with a tenor of tw…

Mandate April 11, 2018

Vinge advises Wilson Therapeutics in connection with the offer from Alexion

Alexion has announced a public cash offer to the shareholders of Wilson Therapeutics AB.

Mandate March 04, 2018

Vinge advises Enea

Enea AB (publ) has signed an agreement to acquire Openwave Mobility for USD 90 million and has issue…

Mandate February 15, 2018

Vinge advises Active Biotech on rights offering

Active Biotech AB (publ) issues new shares with pre-emptive rights for the shareholders.

Mandate February 05, 2018

Vinge advised Medivir on its directed share issue

Vinge advised Medivir AB (publ) in connection with a directed share issue of SEK 155 million through…

Mandate December 12, 2017

Vinge advises Wilson Therapeutics in connection with directed share issue

Vinge has advised Wilson Therapeutics on a directed new issue of shares, whereby Wilson Therapeutics…

Mandate December 12, 2017

Vinge advises Tempest Security in connection with listing on Nasdaq First North

Vinge has advised Tempest Security AB (publ) in connection with its listing on Nasdaq First North. T…

Mandate December 07, 2017

Vinge advised Lifco on bond issue

Lifco AB (publ) has issued two unsecured bond loans of in total SEK 1,000 million, with a tenor of t…

Mandate November 24, 2017

Vinge advises IBT on share issues

Vinge advises Infant Bacterial Therapeutics AB (publ) (Nasdaq First North Premier) in connection wit…

Mandate November 10, 2017

Vinge advises Cantargia on share issues

Vinge advises Cantargia AB (publ) (Nasdaq First North) in connection with a combined directed issue…

Mandate November 02, 2017

Vinge advised Orexo on bond issue

Orexo AB (publ) has issued a four-year senior unsecured bond loan of SEK 325 million, within a frame…

Mandate October 26, 2017

Vinge advised Enea on directed share issue

Vinge has advised Enea AB (publ) in connection with a directed share issue of SEK 141 million throug…

Mandate June 26, 2017

Vinge advises Trianon

Vinge advises Fastighets AB Trianon (publ) in connection with the acquisition of the Entré propertie…

Mandate February 08, 2017

Vinge advises Platzer Fastigheter in conjunction with the acquisition of AB Volvos real estate portfolio in Gothenburg

Vinge has advised Platzer Fastigheter in conjunction with the acquisition of AB Volvo’s real estate…

News

THREE NEW PARTNERS ELECTED AT VINGE IN SKÅNE
Press Release April 22, 2015

THREE NEW PARTNERS ELECTED AT VINGE IN SKÅNE

Advokat Anna Edström, advokat Christoffer Thalin and advokat Kristian Ford all of whom work at Vinge…

Articles

Article April 30, 2015

International Comparative Legal Guide to Mergers and Acquisitions 2015: Sweden

Article September 04, 2014

International Comparative Legal Guide to Corporate Governance 2014: Sweden